Literature DB >> 19778763

Global emm type distribution of group A streptococci: systematic review and implications for vaccine development.

Andrew C Steer1, Irwin Law, Laisiana Matatolu, Bernard W Beall, Jonathan R Carapetis.   

Abstract

emm sequence typing is the most widely used method for defining group A streptococcal (GAS) strains, and has been applied to isolates in all regions of the world. We did a systematic review of the global distribution of GAS emm types. 102 articles and reports were included (38 081 isolates). Epidemiological data from high-income countries were predominant, with sparse data from low-income countries. The epidemiology of GAS disease in Africa and the Pacific region seems to be different from that in other regions, particularly high-income countries. In Africa and the Pacific, there were no dominant emm types, a higher diversity of emm types, and many of the common emm types in other parts of the world were less common (including emm 1, 4, 6, and 12). Our data have implications for the development of GAS vaccines. On the basis of the available data, the current formulation of the experimental multivalent emm vaccine would provide good coverage in high-income countries, particularly USA, Canada, and Europe, but poor coverage in Africa and the Pacific, and only average coverage in Asia and the Middle East.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19778763     DOI: 10.1016/S1473-3099(09)70178-1

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  200 in total

1.  Population genomics: an investigative tool for epidemics.

Authors:  Debra E Bessen
Journal:  Am J Pathol       Date:  2012-02-28       Impact factor: 4.307

2.  Vaccination against rheumatic heart disease: a review of current research strategies and challenges.

Authors:  Manisha Pandey; Michael R Batzloff; Michael F Good
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

3.  Streptococcus pyogenes emm Types and Clusters during a 7-Year Period (2007 to 2013) in Pharyngeal and Nonpharyngeal Pediatric Isolates.

Authors:  F Koutouzi; A Tsakris; P Chatzichristou; E Koutouzis; G L Daikos; E Kirikou; N Petropoulou; V Syriopoulou; A Michos
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

4.  Group A Streptococcus T Antigens Have a Highly Conserved Structure Concealed under a Heterogeneous Surface That Has Implications for Vaccine Design.

Authors:  Paul G Young; Jeremy M Raynes; Jacelyn M Loh; Thomas Proft; Edward N Baker; Nicole J Moreland
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

5.  Epidemiological and molecular analysis of Streptococcus pyogenes isolates causing invasive disease in Spain (1998-2009): comparison with non-invasive isolates.

Authors:  M Montes; C Ardanuy; E Tamayo; A Domènech; J Liñares; E Pérez-Trallero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-15       Impact factor: 3.267

6.  Polymorphisms in Regulator of Cov Contribute to the Molecular Pathogenesis of Serotype M28 Group A Streptococcus.

Authors:  Paul E Bernard; Priyanka Kachroo; Jesus M Eraso; Luchang Zhu; Jessica E Madry; Sarah E Linson; Matthew Ojeda Saavedra; Concepcion Cantu; James M Musser; Randall J Olsen
Journal:  Am J Pathol       Date:  2019-07-29       Impact factor: 4.307

7.  Human IgG Increases Virulence of Streptococcus pyogenes through Complement Evasion.

Authors:  David Ermert; Antonin Weckel; Michal Magda; Matthias Mörgelin; Jutamas Shaughnessy; Peter A Rice; Lars Björck; Sanjay Ram; Anna M Blom
Journal:  J Immunol       Date:  2018-04-06       Impact factor: 5.422

8.  Streptococcus pyogenes bacteraemia, emm types and superantigen profiles.

Authors:  S Rantala; S Vähäkuopus; T Siljander; J Vuopio; H Huhtala; R Vuento; J Syrjänen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-30       Impact factor: 3.267

Review 9.  Variation, Indispensability, and Masking in the M protein.

Authors:  Partho Ghosh
Journal:  Trends Microbiol       Date:  2017-08-31       Impact factor: 17.079

10.  Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197.

Authors:  Ivette Caro-Aguilar; Elizabeth Ottinger; Robert W Hepler; Deborah D Nahas; Chengwei Wu; Michael F Good; Michael Batzloff; Joseph G Joyce; Jon H Heinrichs; Julie M Skinner
Journal:  Hum Vaccin Immunother       Date:  2012-12-18       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.